Therefore, the overexpression of HuR will increase, and the silence of HuR will reduce the expression of dCK protein, thus producing the corresponding gemcitabine response in pancreatic cancer [44]. This evidence concerns the gene ELAVL1 and familial pancreatic carcinoma.